Five-year Clinical follow-up after Revascularization for Chronic Total Coronary Artery Occlusion.
- Author:
Woo Seok PARK
1
;
Myung Ho JEONG
;
Eun Suk SHIN
;
Ju Hyup YUM
;
Seung Hyun LEE
;
Young Joon HONG
;
Ock Young PARK
;
Ju Han KIM
;
Weon KIM
;
Young Keun AHN
;
Jeong Gwan CHO
;
Jong Chun PARK
;
Jung Chaee KANG
Author Information
1. Heart Center Unit of Chonnam National University Hospital, Gwangju, Korea. myungho@chollian.net
- Publication Type:Original Article
- Keywords:
Angioplasty;
Coronary disease;
Revascularization;
Survival
- MeSH:
Angioplasty;
Arteries;
Coronary Artery Bypass;
Coronary Care Units;
Coronary Disease;
Coronary Vessels*;
Death;
Follow-Up Studies*;
Heart;
Humans;
Jeollanam-do;
Percutaneous Coronary Intervention;
Survival Rate;
Transplants
- From:The Korean Journal of Critical Care Medicine
2005;20(1):32-37
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Chronic total occlusion (CTO) has been considered as an unsuitable lesion for percutaneous coronary intervention (PCI) because of technical difficulty and low success rate. Owing to technical advances and increased operator's experience, PCI has been attempted in a large number of patients with CTO in recent years, but there are few long-term follow-up reports for PCI to CTO. METHODS: We analyzed 83 patients (59.7+/-9.2 years, 28 female) with CTO on diagnostic coronary angiogram at the Heart Center and Coronary Care Unit of Chonnam National Hospital from January 1996 to July 1997. The patients were divided into two groups according to revascularization by PCI or CABG (coronary artery bypass graft): the revascularized group (received PCI or CABG, Group I) and non-revascularized group (Group II). RESULTS: PCI was tried in 46 patients and successful in 33 patients (71.7% of the success rate). Eleven patients (13.3%) were treated with the coronary artery bypass graft (CABG) and 31 (37.3%) patients were medically treated. During 5-year clinical follow-up 11 patients died [13.1%; cardiac death 6 (7.1%), non-cardiac death 5 (6.0%)] and the major adverse cardiac events occurred to 24 (28.6%) patients. Cardiac death occurred to one patient of the Group I and 5 patients of Group II (p=0.06). The mean survival time was significantly different (57.8+/-9.2 months in Group I and 50.9+/-19.5 months in Group II, p=0.038). CONCLUSIONS: Revascularization for CTO prolonged the mean survival time of the patients on long- term clinical follow-up.
